Population pharmacokinetic study in children with vascular anomalies: body weight as a key variable in predicting the initial dose and dosing frequency of sirolimus.

MLA

Lin Fan, et al. “Population Pharmacokinetic Study in Children with Vascular Anomalies: Body Weight as a Key Variable in Predicting the Initial Dose and Dosing Frequency of Sirolimus.” Frontiers in Pharmacology, Oct. 2024, pp. 1–13. EBSCOhost, https://doi.org/10.3389/fphar.2024.1457614.

APA

Lin Fan, Hong-Li Guo, Yue-Tao Zhao, Yue Li, Wei-Jun Wang, Jian Huang, Ya-Hui Hu, Ji-Jun Zou, & Feng Chen. (2024). Population pharmacokinetic study in children with vascular anomalies: body weight as a key variable in predicting the initial dose and dosing frequency of sirolimus. Frontiers in Pharmacology, 1–13. https://doi.org/10.3389/fphar.2024.1457614

Chicago

Lin Fan, Hong-Li Guo, Yue-Tao Zhao, Yue Li, Wei-Jun Wang, Jian Huang, Ya-Hui Hu, Ji-Jun Zou, and Feng Chen. 2024. “Population Pharmacokinetic Study in Children with Vascular Anomalies: Body Weight as a Key Variable in Predicting the Initial Dose and Dosing Frequency of Sirolimus.” Frontiers in Pharmacology, October, 1–13. doi:10.3389/fphar.2024.1457614.